An analysis of 65,061 globally recruiting clinical trials across 186 countries finds that 4,361 studies, equivalent to 6.7% ...
Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich Leukemia ...
BALTIMORE, MD, UNITED STATES, April 3, 2026 /EINPresswire.com/ -- Through her contributions to Data-Driven Healthcare, ...
A majority of CKD patients present with cellular inflammation and immunoparalysis predose --Gemini durably normalizes ...
By combining our platform with Trialt’s expertise, we can support sponsors with both the technology and the operational ...
Last June, the FDA signaled how far that integration has progressed when it announced the use of Elsa, a generative AI tool, to support aspects of the drug approval process. While regulatory adoption ...
University Hospital Leipzig relies on its own AI system "LAMPE" to support doctors in real-time diagnoses and therapies.
Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic ...
GLP-1 users are posting about side effects and symptoms not seen in clinical trials, including irregular periods, fatigue, ...
HIPAA applies to doctors, hospitals and insurers — not to consumer AI platforms.
Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces that new clinical data evaluating the accuracy of capillary leak detection scores compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results